Prosecution Insights
Prosecution Insights
8 pending office actions • 1 client • 8 examiners • 8 art units • 0 of 8 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (75%) |
| §112 only | 1 (12%) |
| No statute on record | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOYLAN, JAMES T | 1 | 62.9% | +11.2% |
| PRONZATI, GINA | 1 | 67.7% | +39.0% |
| MEJIAS, SAMANTHA LEE | 1 | 47.8% | +63.2% |
| BORSCH, NICHOLAS S | 1 | 72.5% | +12.1% |
| SHARIFF, MICHAEL ADAM | 1 | 81.5% | +23.6% |
| HUDSON, AMY ROSE | 1 | 75.1% | +11.2% |
| SVEIVEN, MICHAEL CAMERON | 1 | 35.0% | +50.0% |
| BRAUN, MADELINE E | 1 | 68.1% | +25.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17998037 | SYSTEMS AND METHODS FOR CHARACTERIZING A TUMOR MICROENVIRONMENT USING PATHOLOGICAL IMAGES | SHARIFF, MICHAEL ADAM | 46d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17998037 | SYSTEMS AND METHODS FOR CHARACTERIZING A TUMOR MICROENVIRONMENT USING PATHOLOGICAL IMAGES | SHARIFF, MICHAEL ADAM | 46d overdue |
| 17265333 | ADJUVANT EFFECT OF THE TLR1/2 AGONIST DIPROVOCIM SYNERGIZES WITH CHECKPOINT-INHIBITING ANTIBODIES TO ELIMINATE DISEASE | BRAUN, MADELINE E | 42d overdue |
| 18177265 | ENDORECTAL COOLING DEVICE HOLDER | BORSCH, NICHOLAS S | 5d overdue |
| 18933931 | IMAGING SYSTEM AND METHOD TO CONVERT LATERAL SCANNING INTO AXIAL REMOTE FOCUSING | BOYLAN, JAMES T | 2d overdue |
| 18032760 | PROINFLAMMATORY PRODRUGS | MEJIAS, SAMANTHA LEE | 71d |
| 18683101 | SLC13A5 GENE THERAPY VECTORS AND USES THEREOF | PRONZATI, GINA | — |
| 17905285 | METHOD FOR DIAGNOSIS AND/OR PROGNOSIS OF LIVER DISEASE PROGRESSION AND RISK OF HEPATOCELLULAR CARCINOMA AND DISCOVERY OF THERAPEUTIC COMPOUNDS AND TARGETS TO TREAT LIVER DISEASE AND CANCER | HUDSON, AMY ROSE | — |
| 17684639 | METHODS AND COMPOSITIONS FOR DETECTING PROTEIN TARGETS | SVEIVEN, MICHAEL CAMERON | — |
| Client (Assignee) | Pending OAs |
|---|---|
| University of Texas | 8 |
| Art Unit | Apps |
|---|---|
| 2486 | 1 |
| 1633 | 1 |
| 1618 | 1 |
| 3794 | 1 |
| 2672 | 1 |
| 1636 | 1 |
| 1678 | 1 |
| 1624 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18933931 | IMAGING SYSTEM AND METHOD TO CONVERT LATERAL SCANNING INTO AXIAL REMOTE FOCUSING | The Board Of Regents Of The University Of Texas System | BOYLAN, JAMES T | 2486 | §103 | Non-Final OA | 2d overdue | Pending | Oct 31, 2024 |
| 18683101 | SLC13A5 GENE THERAPY VECTORS AND USES THEREOF | The Board Of Regents Of The University Of Texas System | PRONZATI, GINA | 1633 | — | Non-Final OA | — | Pending | Feb 12, 2024 |
| 18032760 | PROINFLAMMATORY PRODRUGS | The Board Of Regents Of The University Of Texas System | MEJIAS, SAMANTHA LEE | 1618 | §103 | Non-Final OA | 71d | Pending | Apr 19, 2023 |
| 18177265 | ENDORECTAL COOLING DEVICE HOLDER | The Board Of Regents Of The University Of Texas System | BORSCH, NICHOLAS S | 3794 | §103 | Final Rejection | 5d overdue | Pending | Mar 02, 2023 |
| 17998037 | SYSTEMS AND METHODS FOR CHARACTERIZING A TUMOR MICROENVIRONMENT USING PATHOLOGICAL IMAGES | The Board Of Regents Of The University Of Texas System | SHARIFF, MICHAEL ADAM | 2672 | §103 | Non-Final OA | 46d overdue | Pending | Nov 06, 2022 |
| 17905285 | METHOD FOR DIAGNOSIS AND/OR PROGNOSIS OF LIVER DISEASE PROGRESSION AND RISK OF HEPATOCELLULAR CARCINOMA AND DISCOVERY OF THERAPEUTIC COMPOUNDS AND TARGETS TO TREAT LIVER DISEASE AND CANCER | The Board Of Regents Of The University Of Texas System | HUDSON, AMY ROSE | 1636 | §103 | Non-Final OA | — | Pending | Aug 30, 2022 |
| 17684639 | METHODS AND COMPOSITIONS FOR DETECTING PROTEIN TARGETS | The Board Of Regents Of The University Of Texas System | SVEIVEN, MICHAEL CAMERON | 1678 | §112 | Non-Final OA | — | Pending | Mar 02, 2022 |
| 17265333 | ADJUVANT EFFECT OF THE TLR1/2 AGONIST DIPROVOCIM SYNERGIZES WITH CHECKPOINT-INHIBITING ANTIBODIES TO ELIMINATE DISEASE | The Board Of Regents Of The University Of Texas System | BRAUN, MADELINE E | 1624 | §103 | Final Rejection | 42d overdue | Pending | Feb 02, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial